EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study

Nurgul Batyrbekova iD, Anna Ravn Landtblom, Malin Hultcrantz iD, Robert Szulkin, Paul W Dickman, Therese M-L Andersson

European Journal of Haematology · 2026

DOI: 10.1111/ejh.70141 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Nurgul Batyrbekova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Myeloproliferative Disorders, Cell Transformation, Neoplastic. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Blodcancerforbundet, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) face transformation risks to acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). While older age is linked to increased risk, it remains unclear whether risk increases with age or with disease duration.

Objectives

To examine how age and disease duration affect AML and MDS transformation in MPN.

Methods

We used Swedish nationwide register data to model transformation rates as continuous functions of age and disease duration for each subtype and outcome. Cumulative incidences were estimated accounting for competing risk of death.

Results

This study included 7156 patients with PV, 6810 with ET, and 1080 with PMF diagnosed in 2001–2021. In PV and ET, AML rates increased with disease duration. In PMF, AML rates were highest soon after diagnosis and declined over time. The 10‐year cumulative incidence of AML at diagnosis age 70 was 3.5% in PV, 4.7% in ET, and 18.2% in PMF; for MDS, it was 1.7%, 3.1%, and 10.7%, respectively.

Conclusion

AML and MDS transformation risks vary by MPN subtype and depend on age and disease duration, with disease duration elevating AML risk in PV and ET; incorporating both factors is essential for individualized risk assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesLeukemia, Myeloid, AcuteMyeloproliferative DisordersCell Transformation, NeoplasticHumansFemaleAgedAged, 80 and overMaleMiddle AgedSwedenIncidenceDisease ProgressionAge FactorsRegistriesAdultRisk FactorsTime Factors

Stichwörter der Autor:innen

AMLMDScohort studydisease durationmyeloproliferative neoplasms

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Nurgul Batyrbekova, Malin Hultcrantz

Förderung

  • Cancerfonden
  • Blodcancerforbundet
  • NCI NIH HHS
  • Vetenskapsrådet
  • Memorial Sloan-Kettering Cancer Center

Zitieren

APA

Batyrbekova, N., Landtblom, A. R., Hultcrantz, M., Szulkin, R., Dickman, P. W., & Andersson, T. M. (2026). Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study. European Journal of Haematology. https://doi.org/10.1111/ejh.70141

Vancouver

Batyrbekova N, Landtblom AR, Hultcrantz M, Szulkin R, Dickman PW, Andersson TM. Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study. European Journal of Haematology. 2026. doi:10.1111/ejh.70141

BibTeX
@article{Batyrbekova2026,
  author = {Batyrbekova, Nurgul and Landtblom, Anna Ravn and Hultcrantz, Malin and Szulkin, Robert and Dickman, Paul W and Andersson, Therese M-L},
  title = {Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study},
  journal = {European Journal of Haematology},
  year = {2026},
  doi = {10.1111/ejh.70141}
}
Kostenlos starten →